SHC
Get informed when a big investor buys or sells
+ FollowOvervalued by 129.6% based on the discounted cash flow analysis.
| Market cap | $5.58 Billion |
|---|---|
| Enterprise Value | $7.49 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.27 |
| Beta | 1.78 |
| Outstanding Shares | 285,773,000 |
| P/E Ratio | 34.14 |
|---|---|
| PEG | 5.95 |
| Price to Sales | 4.63 |
| Price to Book Ratio | 9.26 |
| Enterprise Value to Revenue | 6.16 |
| Enterprise Value to EBIT | 19.85 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 3.41 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 104.29%▲ 7.23% |
|---|---|
| Total Invested | $5.24B▲ 33.30% |
| Investors Holding | 312▲ 14.00% |
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...